Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy

被引:5
|
作者
Sridharan, Aadhavi [1 ]
Maron, Martin S. [1 ]
Carrick, Richard T. [1 ]
Madias, Christopher A. [1 ]
Huang, Dou [1 ]
Cooper, Craig [1 ]
Drummond, Jennifer [1 ]
Maron, Barry J. [1 ]
Rowin, Ethan J. [1 ]
机构
[1] Tufts Med Ctr, HCM Inst, Div Cardiol, 800 Washington St,315, Boston, MA 02111 USA
关键词
atrial fibrillation; comorbidities; hypertrophic cardiomyopathy; obesity; sudden death; OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CLINICAL-COURSE; OBESITY; EXERCISE; PREVALENCE; PHENOTYPE;
D O I
10.1111/jce.15304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The impact of comorbid disease states on the development of atrial and ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM) remains unresolved. Objective Evaluate the association of comorbidities linked to arrhythmias in other cardiovascular diseases (e.g., obesity, systemic hypertension, diabetes, obstructive sleep apnea, renal disorders, tobacco, and alcohol use) to atrial fibrillation (AF) and sudden cardiac death (SCD) events in a large cohort of HCM patients. Methods A total of 2269 patients, 54 +/- 15 years of age, 1392 males, were evaluated at the Tufts HCM Institute between 2004 and 2018 and followed for an average of 4 +/- 3 years for new-onset clinical AF and SCD events (appropriate defibrillation for ventricular tachyarrhythmias, resuscitated cardiac arrest, or SCD). Results One or more comorbidity was present in 75% of HCM patients, including 50% with >= 2 comorbidities, most commonly obesity (body mass index [BMI] >= 30 kg/m(2)) in 43%. New-onset atrial fibrillation developed in 11% of our cohort (2.6%/year). On univariate analysis, obesity was associated with a 1.7-fold increased risk for AF (p = .03) with 12% of obese patients developing AF (3.3%/year) as compared to 7% of patients with BMI < 25 kg/m(2) (1.6%/year; p = .006). On multivariate analysis, age and LA transverse dimension emerged as the only variables predictive of AF. Comorbidities, including obesity, were not independently associated with AF development (p > .10 for each). SCD events occurred in 3.3% of patients (0.8%/year) and neither obesity nor other comorbidities were associated with increased risk for SCD (p > .10 for each). Conclusions In adult HCM patients comorbidities do not appear to impact AF or SCD risk. Therefore, for most patients with HCM, adverse disease related events of AF and SCD appear to be primarily driven by underlying left ventricular and atrial myopathy as opposed to comorbidities.
引用
收藏
页码:20 / 29
页数:10
相关论文
共 50 条
  • [1] Atrial fibrillation is associated with sudden cardiac death risk factors in patients with hypertrophic cardiomyopathy
    Marcuschamer, I. A.
    Zusman, O.
    Schwartzenberg, S.
    Vaturi, M.
    Shapira, Y.
    Kornowski, R.
    Sagie, A.
    Monakier, D.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 486 - 486
  • [2] Relationship of atrial fibrillation to sudden cardiac death in patients with hypertrophic cardiomyopathy: a comparision between obstructive and non-obstructive hypertrophic cardiomyopathy
    Yashiro, B.
    Kajimoto, K.
    Terajima, Y.
    Kawashiro, N.
    Imai, T.
    Hagiwara, N.
    Kasanuki, H.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 447 - 447
  • [3] Relationship of atrial fibrillation to sudden cardiac death in patients with hypertrophic cardiomyopathy: A comparison between obstructive and non-obstructive hypertrophic cardiomyopathy
    Yashiro, B
    Kajimoto, K
    Terajima, Y
    Kawashiro, N
    Imai, T
    Hagiwara, N
    Kasanuki, H
    [J]. CIRCULATION, 2005, 112 (17) : U639 - U639
  • [4] SUDDEN CARDIAC DEATH IN HYPERTROPHIC CARDIOMYOPATHY
    MARON, BJ
    FANANAPAZIR, L
    [J]. CIRCULATION, 1992, 85 (01) : 57 - 63
  • [5] Sudden Cardiac Death in Hypertrophic Cardiomyopathy
    Adamczak, Daria M.
    Oko-Sarnowska, Zofia
    [J]. CARDIOLOGY IN REVIEW, 2018, 26 (03) : 145 - 151
  • [6] Sudden Cardiac Death in Hypertrophic Cardiomyopathy
    O'Mahony, Constantinos
    Elliott, Perry
    McKenna, William
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02): : 443 - 451
  • [7] Hypertrophic cardiomyopathy and sudden cardiac death
    Stroumpoulis, Konstantinos I.
    Pantazopoulos, Ioannis N.
    Xanthos, Theodoros T.
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (09): : 289 - 298
  • [8] Predictors of sudden cardiac death in hypertrophic cardiomyopathy
    Maki, S
    Ikeda, H
    Muro, A
    Yoshida, N
    Shibata, A
    Koga, Y
    Imaizumi, T
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06): : 774 - 778
  • [9] Sudden cardiac death risk in hypertrophic cardiomyopathy
    Ommen, Steve R.
    Gersh, Bernard J.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (21) : 2558 - 2559
  • [10] Prevention of sudden cardiac death in hypertrophic cardiomyopathy
    O'Mahony, Constantinos
    Elliott, Perry M.
    [J]. HEART, 2014, 100 (03) : 254 - 260